These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

361 related items for PubMed ID: 4885744

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [L-dopa treatment and vitamin B 6 --clinical and chemical studies].
    Mawatari S, Izumi K, Kuroiwa Y.
    Rinsho Shinkeigaku; 1972 Feb; 12(2):105-9. PubMed ID: 4674755
    [No Abstract] [Full Text] [Related]

  • 23. L-dopa and parkinsonism.
    Okihiro MM.
    Hawaii Med J; 1971 Feb; 30(5):390-2. PubMed ID: 5160226
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [L-DOPA therapy of parkinsonism].
    Refsum S.
    Nord Med; 1969 May 01; 81(18):570-1. PubMed ID: 5768311
    [No Abstract] [Full Text] [Related]

  • 26. [L-Dopa therapy in Parkinson's disease. A double-blind study].
    Worm-Petersen J, Dupont E, Mikkelsen B.
    Ugeskr Laeger; 1971 Nov 26; 133(47):2321-6. PubMed ID: 4944651
    [No Abstract] [Full Text] [Related]

  • 27. [Treatment of parkinsonism with L-dopa].
    Chouza C, Marín C, Romero S, Gomensoro JB.
    Acta Neurol Latinoam; 1970 Nov 26; 16(1):170-83. PubMed ID: 5538052
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Toulouse-Piéron test in patients with Parkinsonism treated with L-dopa].
    Megna GF, Puca FM, Leggiadro N, Micalizzi V, Pigneri MT.
    Acta Neurol (Napoli); 1973 Nov 26; 28(2):213-22. PubMed ID: 4575429
    [No Abstract] [Full Text] [Related]

  • 30. L-dopa and amantadine hydrochloride in Parkinson's disease.
    Parkes JD, Zilkha KJ, Knill-Jones RP, Clements PJ, Baxter R.
    Int Z Klin Pharmakol Ther Toxikol; 1971 Apr 26; 4(3):356-60. PubMed ID: 4931417
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Preliminary results of the treatment with L-Dopa of 30 patients with Parkinsonism].
    Dumas R, Rahme M, Schott B.
    J Med Lyon; 1971 Apr 20; 52(207):599-615. PubMed ID: 5136571
    [No Abstract] [Full Text] [Related]

  • 34. L-dopa in the treatment of Parkinsonism.
    Brezný I, Buranová D, Cernácek J, Trávniková M.
    Act Nerv Super (Praha); 1972 Apr 20; 14(2):96. PubMed ID: 5040182
    [No Abstract] [Full Text] [Related]

  • 35. A hort-term evaluation of L-dopa therapy in 34 patients with parkinsonism.
    Mones RJ, Elizan TS.
    J Mt Sinai Hosp N Y; 1969 Apr 20; 36(6):503-15. PubMed ID: 5261089
    [No Abstract] [Full Text] [Related]

  • 36. Levodopa in parkinsonism.
    Practitioner; 1972 May 20; 208(247):695-9. PubMed ID: 4560973
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [L-DOPA treatment of parkinsonism: analysis of the clinical course in follow-up cases].
    Ando K, Kono K, Sofue I.
    Nihon Rinsho; 1973 Oct 20; 31(10):2980-6. PubMed ID: 4798116
    [No Abstract] [Full Text] [Related]

  • 40. [Longtime study on the effects of L-dopa therapy in parkinsonism].
    Fischer PA, Schneider E, Jacobi P, Maxion H.
    Nervenarzt; 1973 Mar 20; 44(3):128-35. PubMed ID: 4572536
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.